Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
0.948
+0.016 (1.67%)
At close: Dec 20, 2024, 4:00 PM
0.950
+0.002 (0.25%)
After-hours: Dec 20, 2024, 6:21 PM EST
Artelo Biosciences Employees
Artelo Biosciences had 6 employees as of December 31, 2023. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,520,167
Market Cap
3.06M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ReShape Lifesciences | 29 |
| ENDRA Life Sciences | 21 |
| Petros Pharmaceuticals | 21 |
| Entero Therapeutics | 9 |
| SCWorx | 7 |
| PainReform | 7 |
| Titan Pharmaceuticals | 4 |
| Tharimmune | 3 |
ARTL News
- 12 days ago - Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia - GlobeNewsWire
- 4 weeks ago - Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit - GlobeNewsWire
- 5 weeks ago - Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium - GlobeNewsWire
- 6 weeks ago - Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health's “Preclinical Screening Platform for Pain” Program - GlobeNewsWire
- 2 months ago - Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th - GlobeNewsWire
- 3 months ago - Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor - GlobeNewsWire